retatrutide weight loss phase 2 trial 🧬 Explained Retatrutide is one of the most promising investigational peptides currently being studied for management and metabolic health. Unlike current GLP-1 medications, Retatrutide activates three hormone receptors: • GLP-1 Retatrutide vs Tirzepatide (2026): Differences

Increased FFA in the liver results in insulin resistance, hepatic glucose production, and pancreatic beta cell dysfunction [7]

Injection site rotation is recommended to prevent localized tissue irritation

Week 1: left abdomen

Combining supplemental MOTS-c with HIIT creates a double activation of the fat-browning pathway

Originally developed to help with blood sugar regulation, these medications are now being used to support weight loss, enhance metabolic health, and treat diabetes, inflammation, and other health conditions

The starting plan depends on the previous product, reported dose, time since the last injection, side effects, medical history, and treatment goals